Details
Stereochemistry | MIXED |
Molecular Formula | C22H34NO2 |
Molecular Weight | 344.5109 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
C[N+]4(CC1COC(O1)(C2CCCCC2)C3=CC=CC=C3)CCCCC4
InChI
InChIKey=AXWZZEWIGNYBGA-UHFFFAOYSA-N
InChI=1S/C22H34NO2/c1-23(15-9-4-10-16-23)17-21-18-24-22(25-21,19-11-5-2-6-12-19)20-13-7-3-8-14-20/h2,5-6,11-12,20-21H,3-4,7-10,13-18H2,1H3/q+1
Molecular Formula | C22H34NO2 |
Molecular Weight | 344.5109 |
Charge | 1 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: Description was created based on several sources, including http://www.genome.jp/dbget-bin/www_bget?D01815 and http://america.pink/oxapium-iodide_3370799.html
Curator's Comment: Description was created based on several sources, including http://www.genome.jp/dbget-bin/www_bget?D01815 and http://america.pink/oxapium-iodide_3370799.html
Oxapium iodide (ciclonium or cyclonium, trade name Oxaperan, Esperan) is an antispasmodic indicated for the treatment of gastritis, gastroduodenal ulcer, enteritis, and other conditions. It is marketed in South Korea by Dongsung Pharmaceuticals and by Taisho Toyama Pharmaceutical Co., Ltd. in Japan. Oxapium is a muscarinic cholinergic receptor antagonist. It has two separate pharmacological effects: (1) a potent atropine-like action, (2) a papaverine-like action.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094109 Sources: http://www.genome.jp/dbget-bin/www_bget?D01815 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | ESPERAN Approved UseImprovement of pain due to spasms and motility disorder in the following diseases: Gastritis, Gastroduodenal ulcer, Enteritis, Gallbladder and biliary disease, Urinary calculus Launch Date1971 |
|||
Palliative | ESPERAN Approved UseImprovement of pain due to spasms and motility disorder in the following diseases: Gastritis, Gastroduodenal ulcer, Enteritis, Gallbladder and biliary disease, Urinary calculus Launch Date1971 |
|||
Palliative | ESPERAN Approved UseImprovement of pain due to spasms and motility disorder in the following diseases: Gastritis, Gastroduodenal ulcer, Enteritis, Gallbladder and biliary disease, Urinary calculus Launch Date1971 |
Sample Use Guides
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:56:42 GMT 2023
by
admin
on
Sat Dec 16 01:56:42 GMT 2023
|
Record UNII |
IK8HSQ3YBL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4613
Created by
admin on Sat Dec 16 01:56:42 GMT 2023 , Edited by admin on Sat Dec 16 01:56:42 GMT 2023
|
PRIMARY | |||
|
SUB03562MIG
Created by
admin on Sat Dec 16 01:56:42 GMT 2023 , Edited by admin on Sat Dec 16 01:56:42 GMT 2023
|
PRIMARY | |||
|
IK8HSQ3YBL
Created by
admin on Sat Dec 16 01:56:42 GMT 2023 , Edited by admin on Sat Dec 16 01:56:42 GMT 2023
|
PRIMARY | |||
|
100000085486
Created by
admin on Sat Dec 16 01:56:42 GMT 2023 , Edited by admin on Sat Dec 16 01:56:42 GMT 2023
|
PRIMARY | |||
|
Oxapium
Created by
admin on Sat Dec 16 01:56:42 GMT 2023 , Edited by admin on Sat Dec 16 01:56:42 GMT 2023
|
PRIMARY | |||
|
17834-29-6
Created by
admin on Sat Dec 16 01:56:42 GMT 2023 , Edited by admin on Sat Dec 16 01:56:42 GMT 2023
|
PRIMARY | |||
|
21993
Created by
admin on Sat Dec 16 01:56:42 GMT 2023 , Edited by admin on Sat Dec 16 01:56:42 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID3048235
Created by
admin on Sat Dec 16 01:56:42 GMT 2023 , Edited by admin on Sat Dec 16 01:56:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |